The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pilot study of MAGE-A3 protein vaccination and autologous stem cell transplantation (autoSCT) as consolidation therapy for multiple myeloma (MM).
Adam D. Cohen
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Onyx
Honoraria - Celgene
Nikoletta Lendvai
No relevant relationships to disclose
Sacha Gnjatic
Employment or Leadership Position - Ludwig Institute for Cancer Research
Achim A Jungbluth
Employment or Leadership Position - Ludwig Institute for Cancer Research
Linda S. Pan
Employment or Leadership Position - Ludwig Institute for Cancer Research
Stephane V. Bertolini
Employment or Leadership Position - Ludwig Institute for Cancer Research
Ralph Rudolph Venhaus
Employment or Leadership Position - Ludwig Institute for Cancer Research
Stock Ownership - Agenus
Rafik Fellague-Chebra
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Olivier Gruselle
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Hearn J. Cho
No relevant relationships to disclose